Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin Dose-Response for Placental Function in Preeclampsia History
NCT01352234Phase 4Completed
- Sponsor
- CHU de Québec-Université Laval
- Start
- Sep 2011
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in preeclampsia, placental insufficiency, fetal growth restriction (FGR), preterm birth, sponsored by CHU de Québec-Université Laval. Started Sep 2011; status: completed.
02
Drugs
aspirin
03
Conditions
preeclampsiaplacental insufficiencyfetal growth restriction (FGR)preterm birth
Beyond the preview
Go deeper on NCT01352234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01352234.